Posted in | Protein Analysis

Enlightening the Fcab-antigen interaction via X-ray crystallography & solution studies

The modular nature of antibodies allows the design of antibody-related formats with tailored characteristics. The antibody’s Fc part, encompassing the effector functions, represents an attractive scaffold for engineering therapeutic molecules as demonstrated by the generation of Fcabs (Fc domain with antigen-binding sites). By engineering the C-terminal loops (AB, CD and EF loop) in the CH3 domains, two antigen binding sites can be inserted in close proximity.

The study presented in this webinar deals with the determination of the first X-ray structures of three Fcabs that differ in loop design, specificity, affinity and thermal stability and reveals their overall structural integrity and native fold.

Furthermore, by investigation of the interaction of these Fcabs with their respective antigens (HER2 or VEGF) using a set of complementary techniques (X-ray crystallography, size exclusion chromatography combined with multi-angle light scattering [SEC-MALS], isothermal titration calorimetry [ITC], fluorescence correlation spectroscopy [FCS]), insights into the binding modes and binding stoichiometries were gained.


May 15 2018 - May 15 2018
10:30 - 11:30
(GMT-05:00) Eastern [US & Canada]
Event type:
Webinar - Live
Size Exclusion Chromatography (SEC)
X-ray Diffraction (XRD)
Isothermal Titration Calorimetry (ITC)


Elisabeth Lobner is a post-doctoral researcher in the Department of Biotechnology at the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria. Her current research mainly focuses on the application of animal cell factories, particularly on difficult-to-express proteins. During her 4-year tenure as a PhD student at the Department of Chemistry (BOKU) in cooperation with F-star Biotechnology Ltd., she investigated the interaction between certain antibody-fragments and their respective antigens. Before this, Elisabeth completed her Master’s degree in biotechnology at BOKU.

More information

Who should attend?
Everyone who focuses on antibodies and antibody fragments and is interested in state-of-the-art biophysical methods to analyze protein-protein interactions.

What will you learn?
The presented study demonstrates how to apply and exploit complementary biophysical methods to shed light on protein-protein interactions.

Other Webinars from Malvern Panalytical

Tell Us What You Think

Do you have a review, update or anything you would like to add to this content?

Leave your feedback
Your comment type

Materials Webinars by Subject Matter

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.